In furtherance to the Board Meeting Notice dated 06th February 2026, we wish to inform you that at the meeting of Board of Directors of M/s. Phyto Chem (India) Limited held today i.e. on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) reported weak Q3 FY26 results with revenue from operations falling to Rs 297.12 lakhs from Rs 364.69 lakhs a year ago, an ~18.5% decline. Total revenue for the quarter stood at Rs 327.88 lakhs versus Rs 559.05 lakhs in Q3 FY25, dragged lower by sharply reduced other income. For the nine months ended December 2025, revenue from operations dropped ~30% to Rs 883.89 lakhs from Rs 1,262.24 lakhs. The company swung to a net loss of Rs 48.45 lakhs in Q3 (vs a profit of Rs 152.05 lakhs last year) and a cumulative nine-month loss of Rs 152.65 lakhs (vs a profit of Rs 16.35 lakhs). Loss per share for the nine-month period was Rs 3.55 versus earnings of Rs 0.38 a year ago. The statutory auditor issued an unmodified limited review report with no qualifications.
Persistent losses, shrinking top line and margin compression point to continued operational stress; near-term stock sentiment is likely negative until revenue and profitability show a clear turnaround.